Evidence map›Paper›PMID 35047106›Full record

ArticleOxidative medicine and cellular longevity2022

Superoxide Dismutase Prevents SARS-CoV-2-Induced Plasma Cell Apoptosis and Stabilizes Specific Antibody Induction.

Li-Hua Mo, Xiang-Qian Luo, Ke Ma, Jian-Bo Shao, Guo-Hao Zhang, Zhi-Gang Liu, Da-Bo Liu, Huan-Ping Zhang, Ping-Chang Yang

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Li-Hua MoDepartment of Pediatric Otolaryngology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Xiang-Qian LuoDepartment of Pediatric Otolaryngology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Ke MaDepartment of Allergy Medicine, Bethune Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
Jian-Bo ShaoDepartment of Pediatric Otolaryngology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Guo-Hao ZhangInstitute of Allergy & Immunology, Shenzhen University School of Medicine, State Key Laboratory of Respiratory Disease Allergy Division at Shenzhen University, Shenzhen, China.
Zhi-Gang LiuInstitute of Allergy & Immunology, Shenzhen University School of Medicine, State Key Laboratory of Respiratory Disease Allergy Division at Shenzhen University, Shenzhen, China.
Da-Bo LiuDepartment of Pediatric Otolaryngology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.ORCID https://orcid.org/0000-0001-7504-2668
Huan-Ping ZhangDepartment of Allergy Medicine, Bethune Hospital Affiliated to Shanxi Medical University, Taiyuan, China.ORCID https://orcid.org/0000-0002-6938-6576
Ping-Chang YangGuangdong Provincial Key Laboratory of Regional Immunity and Diseases, Shenzhen, China.ORCID https://orcid.org/0000-0002-6806-9464
Shenzhen University · CNShanxi Medical University · CNSouthern Medical University Shenzhen Hospital · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The infection of coronavirus disease (COVID-19) seriously threatens human life. It is urgent to generate effective and safe specific antibodies (Abs) against the pathogenic elements of COVID-19. Mice were immunized with SARS-CoV-2 spike protein antigens: S ectodomain-1 (CoV, in short) mixed in Alum adjuvant for 2 times and boosted with CoV weekly for 6 times. A portion of mice were treated with Maotai liquor (MTL, in short) or/and heat stress (HS) together with CoV boosting. We observed that the anti-CoV Ab was successfully induced in mice that received the CoV/Alum immunization for 2 times. However, upon boosting with CoV, the CoV Ab production diminished progressively; spleen CoV Ab-producing plasma cell counts reduced, in which substantial CoV-specific Ab-producing plasma cells (sPC) were apoptotic. Apparent oxidative stress signs were observed in sPCs; the results were reproduced by exposing sPCs to CoV in the culture. The presence of MTL or/and HS prevented the CoV-induced oxidative stress in sPCs and promoted and stabilized the CoV Ab production in mice in re-exposure to CoV. In summary, CoV/Alum immunization can successfully induce CoV Ab production in mice that declines upon reexposure to CoV. Concurrent administration of MTL/HS stabilizes and promotes the CoV Ab production in mice.

Indexed as

ApoptosisAdjuvants, ImmunologicAlcoholic BeveragesAlum CompoundsAngiotensin-Converting Enzyme 2AnimalsAntibodies, NeutralizingAntibodies, ViralCOVID-19COVID-19 VaccinesHeat-Shock ResponseImmunization, SecondaryImmunogenicity, VaccineJanus Kinase 2MaleMiceAce2 protein, mouseAdjuvants, ImmunologicAlum Compoundsaluminum sulfateAngiotensin-Converting Enzyme 2Antibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesJak2 protein, mouseJanus Kinase 2Reactive Oxygen SpeciesSod1 protein, mouseSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Stat1 protein, mouseSTAT1 Transcription FactorSuperoxide Dismutase-1

Identifiers

PMID35047106
PMCPMC8762758
OpenAlexW4205409116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.